Clinical Trial Detail

NCT ID NCT03335267
Title Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

acute myeloid leukemia

Therapies

CPX-351

Age Groups: adult senior

No variant requirements are available.